Incyte Corp (NASDAQ:INCY)

107.69
Delayed Data
As of May 22
 -0.72 / -0.66%
Today’s Change
43.86
Today|||52-Week Range
111.93
+47.30%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close108.41
Today’s open108.00
Day’s range107.19 - 109.11
Volume694,683
Average volume (3 months)1,192,047
Market cap$19.3B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+11.83%
Earnings growth (next 5 years)+219.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc+1.70+0.65%
BMRNBiomarin Pharmaceuti...+0.31+0.24%
HSPHospira Inc-0.04-0.05%
ENDPEndo International P...-0.08-0.09%
Data as of 4:03pm ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers